Published in Thromb Haemost on August 01, 2003
Plasminogen activator inhibitor-1 regulates myoendothelial junction formation. Circ Res (2010) 1.05
Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke (2012) 0.93
Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands. J Biol Chem (2008) 0.91
Functional stability of plasminogen activator inhibitor-1. ScientificWorldJournal (2014) 0.87
Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition. Protein Sci (2011) 0.84
Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes. Protein Sci (2011) 0.83
Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers. Nucleic Acid Ther (2014) 0.79
α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis. Am J Pathol (2013) 0.75
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem (2004) 1.95
Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem (2005) 1.89
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem (2003) 1.87
Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. J Biol Chem (2004) 1.86
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One (2009) 1.80
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J (2002) 1.70
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med (2003) 1.67
Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem (2007) 1.66
Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med (2007) 1.50
Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor. Circ Res (2007) 1.48
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1. Proc Natl Acad Sci U S A (2012) 1.46
Proteome reference maps of the Lotus japonicus nodule and root. Proteomics (2014) 1.39
Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J (2003) 1.35
Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem (2002) 1.29
Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas. Biochemistry (2004) 1.25
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J Am Chem Soc (2014) 1.22
Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation (2002) 1.22
Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol (2004) 1.18
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res (2012) 1.17
Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med (2002) 1.17
Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol (2009) 1.15
Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2003) 1.14
Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost (2004) 1.11
Plasminogen activator inhibitor-1. Curr Med Chem (2004) 1.10
MS Data Miner: a web-based software tool to analyze, compare, and share mass spectrometry protein identifications. Proteomics (2012) 1.10
A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by Staphopain B in human neutrophils and monocytes. J Innate Immun (2008) 1.10
A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037. Biol Chem (2010) 1.08
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol (2003) 1.05
Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase. J Biol Chem (2002) 1.04
Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C. J Biol Chem (2006) 1.04
Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J Med Chem (2007) 1.03
The TSG-6 and I alpha I interaction promotes a transesterification cleaving the protein-glycosaminoglycan-protein (PGP) cross-link. J Biol Chem (2005) 1.03
The transfer of heavy chains from bikunin proteins to hyaluronan requires both TSG-6 and HC2. J Biol Chem (2008) 1.03
The dual nature of human extracellular superoxide dismutase: one sequence and two structures. Proc Natl Acad Sci U S A (2003) 1.02
Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp. J Biol Chem (2010) 1.02
Cantilever sensor for nanomechanical detection of specific protein conformations. Nano Lett (2005) 1.02
Optimal control based NCO and NCA experiments for spectral assignment in biological solid-state NMR spectroscopy. J Magn Reson (2007) 1.02
Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab (2005) 1.01
A new autocatalytic activation mechanism for cysteine proteases revealed by Prevotella intermedia interpain A. J Biol Chem (2007) 1.01
Catalytic properties of ADAM12 and its domain deletion mutants. Biochemistry (2007) 1.01
Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J Mol Neurosci (2007) 1.01
Proteomic analysis of the soluble fraction from human corneal fibroblasts with reference to ocular transparency. Mol Cell Proteomics (2004) 1.00
The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities. Biochem J (2005) 1.00
Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa. J Med Chem (2008) 0.99
Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene. Exp Eye Res (2011) 0.99
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun (2003) 0.98
Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging. Exp Eye Res (2009) 0.98
Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials. Invest Ophthalmol Vis Sci (2003) 0.98
Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications. Biochem J (2010) 0.97
A dataset of human cornea proteins identified by Peptide mass fingerprinting and tandem mass spectrometry. Mol Cell Proteomics (2005) 0.97
The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost (2004) 0.97
The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. Matrix Biol (2009) 0.97
The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand. FEBS Lett (2002) 0.96
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem (2011) 0.96
Focus on molecules: Transforming growth factor beta induced protein (TGFBIp). Exp Eye Res (2007) 0.96
The intracellular proteolytic processing of extracellular superoxide dismutase (EC-SOD) is a two-step event. J Biol Chem (2004) 0.96
The protein composition of the digestive fluid from the venus flytrap sheds light on prey digestion mechanisms. Mol Cell Proteomics (2012) 0.95
Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol (2007) 0.95
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. Free Radic Biol Med (2002) 0.95
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Biochem J (2002) 0.95
Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation. Arterioscler Thromb Vasc Biol (2007) 0.94
The proteome of seed development in the model legume Lotus japonicus. Plant Physiol (2009) 0.94
Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells. Neoplasia (2011) 0.93
Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J Proteome Res (2012) 0.93
Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1. Mol Cell Proteomics (2007) 0.92
Biosimilar monoclonal antibodies: a science-based regulatory challenge. Expert Opin Biol Ther (2013) 0.91
Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1. Biochem J (2003) 0.91
The major allergen from birch tree pollen, Bet v 1, binds and permeabilizes membranes. Biochemistry (2007) 0.91
A novel mode of intervention with serine protease activity: targeting zymogen activation. J Biol Chem (2008) 0.91
TSG-6 transfers proteins between glycosaminoglycans via a Ser28-mediated covalent catalytic mechanism. J Biol Chem (2008) 0.91
Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1. J Biol Chem (2012) 0.90
Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am J Clin Pathol (2004) 0.90
Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect Immun (2012) 0.90
The TSG-6/HC2-mediated transfer is a dynamic process shuffling heavy chains between glycosaminoglycans. J Biol Chem (2010) 0.90
Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking. J Biol Chem (2013) 0.90
Large scale isolation and purification of soluble RAGE from lung tissue. Protein Expr Purif (2008) 0.90
RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Biochemistry (2010) 0.90
Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One (2011) 0.89
Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain. J Biol Chem (2008) 0.89
Hydrogen peroxide induce modifications of human extracellular superoxide dismutase that results in enzyme inhibition. Redox Biol (2013) 0.89
Transfer of inter-alpha-inhibitor heavy chains to hyaluronan by surface-linked hyaluronan-TSG-6 complexes. J Biol Chem (2008) 0.89
Platelets retain high levels of active plasminogen activator inhibitor 1. PLoS One (2011) 0.89
Atypical asymmetric lattice corneal dystrophy associated with a novel homozygous mutation (Val624Met) in the TGFBI gene. Mol Vis (2008) 0.89
Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidase. J Biol Chem (2006) 0.89
Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin. Thromb Res (2008) 0.88
Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1. J Struct Biol (2007) 0.88
Development of ELISAs measuring the extent of TAFI activation. Arterioscler Thromb Vasc Biol (2005) 0.88